Related Experiment Video
Updated: Dec 9, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19
Seshadri Reddy Varikasuvu1, Saurabh Varshney2, Naveen Dutt3
1Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Deoghar, Jharkhand, 814152, India. lifeschemistry@live.com.
Insights
Diabetic patients with COVID-19 showed significantly higher levels of inflammatory markers and coagulation dysfunction compared to non-diabetic patients. This suggests increased susceptibility to severe complications in diabetic individuals.
Area of Science:
- Medical research
- Infectious diseases
- Endocrinology
Background:
- COVID-19 presents diverse clinical manifestations, with a notable impact on coagulation and inflammation.
- Diabetes mellitus is a known risk factor for severe infections and adverse outcomes.
- Understanding the interplay between diabetes, COVID-19, and hypercoagulability is crucial for patient management.
Discussion:
- Diabetic COVID-19 patients exhibited elevated serum ferritin, C-reactive protein, interleukin-6, fibrinogen, and D-dimers.
- These findings indicate a heightened inflammatory response and pro-thrombotic state in diabetic individuals with COVID-19.
- The observed differences were statistically significant, suggesting a genuine biological effect.
Key Insights:
- Diabetic COVID-19 patients experience more severe inflammation and coagulation dysfunction.
- Markers such as serum ferritin, CRP, IL-6, fibrinogen, and D-dimers are significantly elevated.
- This heightened inflammatory and hypercoagulable state may predispose diabetic patients to worse COVID-19 outcomes.
Outlook:
- Further research is warranted to explore the specific mechanisms driving these differences.
- Investigating targeted therapeutic strategies for diabetic COVID-19 patients is essential.
- Long-term follow-up studies can elucidate the chronic implications of these findings.
Abstract:
Coagulation dysfunction and inflammatory status were compared between diabetic and non-diabetic COVID-19 patients. The standardized mean difference (SMD) and its 95% confidence interval (CI) was computed for the difference of inflammatory and hypercoagulability markers. The levels of serum ferritin (standardized mean difference-SMD: 0.47, CI 0.17-0.77, p = 0.002), C-reactive protein (SMD = 0.53, CI 0.20-0.86, p = 0.002), interleukin-6 (SMD = 0.31, CI 0.09-0.52, p = 0.005), fibrinogen (SMD = 0.31, CI 0.09-0.54, p = 0.007) and D-dimers (SMD = 0.54, CI 0.16-0.91, p = 0.005) were significantly higher in diabetic COVID-19 cases as compared to non-diabetic COVID-19 patients, suggesting more susceptibility of diabetic COVID-19 patients to coagulation dysfunction and inflammatory storm.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Diabetes: Symptoms, Diagnosis, and Complications
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

